From designing molecules to making medicines: AI drug discovery enters its next phase
AI is moving from lab novelty to clinical reality. The next test is whether faster molecule…
Early Shanghai trial data points to promise for therapeutic mRNA cancer vaccines
By Da Cheung The American Society of Clinical Oncology (ASCO) annual meeting, which concluded on June…
Latest
- Token exports are emerging as a new business for Chinese AI companies
- Space robotics startup Guoyu Xingchen raises nearly 100 million yuan in Series A funding round
- Tencent taps free micro-dramas to challenge ByteDance in the battle for screen time
- StepFun’s first AI agent smartphone undercuts ByteDance’s Doubao by 2,000 yuan
- China’s oral GLP-1 weight-loss pills advance as seven candidates race to market
